Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ACHE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
FOXC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BDKRB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC01020 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SPEF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR1909 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APOC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NPAS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MMP25-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PKDREJ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC8B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FEM1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNNC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SVIL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIRREL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LBX1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on